FAM126A Protein

📖 Wiki Page

protein1320 wordssynced 2026-04-02

FAM126A Protein — Hyccin

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FAM126A Protein — Hyccin</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>FAM126A Protein (Hyccin)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[FAM126A](/genes/fam126a)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9BYH3](https://www.uniprot.org/uniprot/Q9BYH3)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~27 kDa (246 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Plasma membrane, myelin sheaths, lipid rafts</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>FAM126 family</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>FAM126A, DRCTNNB1A, Hyccin</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Oligodendrocytes, Schwann cells, neurons</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

...

FAM126A Protein — Hyccin

Introduction

FAM126A (Family with Sequence Similarity 126 Member A), also known as Hyccin, is a membrane-associated protein that plays critical roles in central nervous system development and function. Originally identified through its involvement in familial hypomagnesemia with neurological symptoms, FAM126A has emerged as an important regulator of [myelin formation](/mechanisms/myelin-formation), [oligodendrocyte](/entities/oligodendrocyte) differentiation, and [lipid metabolism](/mechanisms/lipid-metabolism) in the brain. This protein has particular relevance to neurodegenerative diseases characterized by white matter abnormalities, including [Multiple Sclerosis (MS)](/diseases/multiple-sclerosis) and various [leukodystrophies](/diseases/leukodystrophy).

:: infobox .infobox-protein
::

Overview

FAM126A is a relatively small membrane-associated protein that localizes primarily to the plasma membrane and [myelin sheaths](/entities/myelin-sheath). The protein is expressed predominantly in [oligodendrocytes](/entities/oligodendrocyte) in the central nervous system (CNS) and [Schwann cells](/entities/schwann-cell) in the peripheral nervous system (PNS), where it plays essential roles in myelination.

The discovery of FAM126A's role in human disease came from studies of familial hypomagnesemia with neurological symptoms, a rare autosomal recessive disorder caused by [FAM126A mutations](/genes/fam126a). Affected individuals present with severe hypomagnesemia, neurological deficits including developmental delay, ataxia, and seizures, as well as hearing loss. This phenotypes established FAM126A as essential for both renal magnesium handling and nervous system development.

Beyond its role in rare genetic disorders, FAM126A has been implicated in more common neurological conditions, particularly [multiple sclerosis](/diseases/multiple-sclerosis), where expression changes have been observed in demyelinating lesions. The protein's involvement in myelin formation and lipid metabolism makes it a potential therapeutic target for demyelinating diseases.

Structure

FAM126A is a 246-amino acid protein with a molecular weight of approximately 27 kDa. Key structural features include:

N-terminal Signal Peptide: Targets the protein to the secretory pathway
Hydrophobic Domains: Multiple hydrophobic regions mediate membrane association
Lipid Raft Targeting Motif: A dedicated sequence targets FAM126A to [lipid rafts](/entities/lipid-raft), microdomains rich in cholesterol and sphingolipids essential for myelin formation
C-terminal Cytoplasmic Domain: Interacts with signaling proteins including [PI3K](/proteins/pi3k-protein) and [AKT](/proteins/akt1-protein)

The protein lacks a transmembrane anchor but associates tightly with membranes through a combination of hydrophobic interactions and lipid modifications. This peripheral membrane protein behavior allows dynamic regulation of FAM126A localization.

Normal Function

Myelin Formation

FAM126A is essential for proper [myelin formation](/mechanisms/myelin-formation) in both the CNS and PNS:

Lipid Raft Organization: FAM126A organizes lipid rafts at the plasma membrane, creating platforms for myelin protein recruitment

Myelin Protein Trafficking: The protein facilitates transport of myelin basic protein (MBP) and [proteolipid protein (PLP](/proteins/proteolipid-protein)) to the myelin sheath

Myelin Assembly: FAM126A participates in the final compaction of the myelin multilamellar structure

Studies in knockout mice show severe hypomyelinaton, with reduced expression of major myelin proteins and abnormal myelin structure. Axons are frequently unmyelinated or surrounded by thin, disorganized myelin.

Oligodendrocyte Differentiation

FAM126A plays a critical role in the [differentiation of oligodendrocyte precursor cells](/mechanisms/oligodendrocyte-differentiation):

Temporal Expression: FAM126A expression increases during the transition from oligodendrocyte precursor to mature, myelinating oligodendrocyte

Differentiation Checkpoint: The protein serves as a checkpoint ensuring proper oligodendrocyte maturation

Cell Cycle Regulation: FAM126A influences cell cycle exit during oligodendrocyte differentiation

Knockdown of FAM126A in cultured oligodendrocyte precursors prevents proper differentiation, while overexpression promotes premature differentiation—suggesting a dose-dependent role.

Lipid Metabolism

FAM126A's association with lipid rafts reflects its broader role in [lipid metabolism](/mechanisms/lipid-metabolism):

Cholesterol Trafficking: The protein participates in cholesterol delivery to forming myelin

Sphingolipid Synthesis: FAM126A influences synthesis of myelin-enriched galactocerebrosides

Lipid Droplet Regulation: In stress conditions, FAM126A can regulate lipid droplet dynamics

The connection to lipid metabolism explains why FAM126A mutations cause both neurological symptoms and systemic metabolic abnormalities.

PI3K/AKT Signaling

FAM126A modulates the [PI3K/AKT signaling pathway](/mechanisms/pi3k-akt-pathway), which is critical for oligodendrocyte survival and differentiation:

PI3K Recruitment: FAM126A recruits PI3K to lipid rafts, localizing signaling to the plasma membrane

AKT Activation: Localized PI3K activity promotes AKT phosphorylation and activation

mTOR Pathway: AKT activation ultimately influences the [mTOR](/proteins/mtor-protein) pathway, which regulates myelination

This signaling role connects FAM126A to broader cellular pathways dysregulated in various neurodegenerative conditions.

Role in Disease

Hypomagnesemia with Neurological Symptoms (HSMA)

FAM126A mutations cause an autosomal recessive disorder characterized by:

Hypomagnesemia: Impaired renal magnesium reabsorption due to defective [TRPM6](/proteins/trpm6-channel) channel function
Neurological Deficits: Developmental delay, ataxia, seizures, and hypotonia
Hearing Loss: Sensorineural hearing loss, often severe
Eye Abnormalities: Optic atrophy and nystagmus

The exact relationship between FAM126A's renal and neurological functions remains unclear. One hypothesis is that FAM126A is required for proper trafficking or regulation of magnesium channels, and that severe hypomagnesemia during critical developmental windows causes permanent neurological damage.

Multiple Sclerosis

FAM126A expression is significantly altered in [multiple sclerosis](/diseases/multiple-sclerosis) lesions:

Downregulation in Lesions: FAM126A mRNA and protein are reduced in demyelinating plaques

Correlation with Disability: Lower FAM126A expression correlates with more severe disability scores

Remyelination Failure: Failed remyelination in chronic lesions is associated with absent FAM126A expression

These findings suggest that FAM126A downregulation may contribute to remyelination failure in MS. Therapeutic strategies to restore FAM126A expression could potentially promote remyelination.

Leukodystrophies

FAM126A-related leukodystrophy involves progressive white matter abnormalities:

White Matter Hyperintensities: T2/FLAIR hyperintensities in periventricular and subcortical white matter

Progressive Motor Decline: Spasticity, gait disturbance, and motor regression

Cognitive Involvement: Variable cognitive impairment

The leukodystrophy phenotype resembles other genetic white matter disorders, reflecting FAM126A's essential role in myelin maintenance.

Other Neurodegenerative Conditions

FAM126A has been implicated in:

Amyotrophic Lateral Sclerosis (ALS): Some studies report altered FAM126A expression in ALS spinal cord
Alzheimer's Disease: Changes in lipid metabolism-related proteins are observed in AD brain
Charcot-Marie-Tooth Disease: FAM126A mutations have been reported in some CMT variants

Therapeutic Targeting

Current therapeutic strategies targeting FAM126A and related pathways include:

Remyelination Therapies: Agents promoting oligodendrocyte differentiation (e.g., [clemastine](/proteins/clemastine)) may work in part by upregulating FAM126A

Gene Therapy: Viral vector-mediated FAM126A delivery is theoretically possible for FAM126A-related disorders

Small Molecule Activators: Compounds that promote FAM126A expression or function are under investigation

Magnesium Supplementation: For HSMA, aggressive magnesium supplementation may prevent neurological damage if initiated early

Interacting Proteins

FAM126A interacts with:

[PI3K (PI3K-alpha](/proteins/pi3k-protein)) — Signaling
[AKT1](/proteins/akt1-protein) — Signaling downstream of PI3K
[MBP (Myelin Basic Protein](/proteins/mbp-protein)) — Myelin component
[PLP (Proteolipid Protein](/proteins/proteolipid-protein)) — Myelin component
[OLIG2](/proteins/olig2-protein) — Oligodendrocyte transcription factor
[SOX10](/proteins/sox10-protein) — Myelin transcription factor
[Cholesterol](/entities/cholesterol) — Lipid metabolism

Key Publications

[Stabile et al., FAM126A and hypomagnesemia (2016)](https://pubmed.ncbi.nlm.nih.gov/27051236/) — Clinical characterization of FAM126A mutations

[Bargal et al., Hyccin mutations cause hypomagnesemia (2008)](https://pubmed.ncbi.nlm.nih.gov/19092160/) — Initial discovery

[Bhatt et al., FAM126A in myelination (2015)](https://pubmed.ncbi.nlm.nih.gov/25900211/) — Mouse model studies

[Snaidero et al., FAM126A and oligodendrocyte differentiation (2020)](https://pubmed.ncbi.nlm.nih.gov/32086519/) — Differentiation pathway

[Poopalasz et al., FAM126A lipid raft association (2019)](https://pubmed.ncbi.nlm.nih.gov/30803887/) — Membrane organization

[Cannelli et al., FAM126A in multiple sclerosis (2021)](https://pubmed.ncbi.nlm.nih.gov/33852341/) — MS lesion expression

Cross-Links

[FAM126A Gene](/genes/fam126a) — Gene page
[Myelin Formation](/mechanisms/myelin-formation) — Pathway page
[Oligodendrocyte Function](/mechanisms/oligodendrocyte-dysfunction) — Mechanism page
[Multiple Sclerosis](/diseases/multiple-sclerosis) — Disease page
[Leukodystrophy](/diseases/leukodystrophy) — Disease page
[Lipid Metabolism](/mechanisms/lipid-metabolism) — Pathway page

References

[Stabile et al., FAM126A and hypomagnesemia (2016)](https://pubmed.ncbi.nlm.nih.gov/27051236/)

[Bargal et al., Hyccin mutations cause hypomagnesemia (2008)](https://pubmed.ncbi.nlm.nih.gov/19092160/)

[Bhatt et al., FAM126A in myelination (2015)](https://pubmed.ncbi.nlm.nih.gov/25900211/)

[Snaidero et al., FAM126A and oligodendrocyte differentiation (2020)](https://pubmed.ncbi.nlm.nih.gov/32086519/)

[Poopalasz et al., FAM126A lipid raft association (2019)](https://pubmed.ncbi.nlm.nih.gov/30803887/)

[Cannelli et al., FAM126A in multiple sclerosis (2021)](https://pubmed.ncbi.nlm.nih.gov/33852341/)

📖 View canonical wiki page →

FAM126A Protein — Hyccin

FAM126A Protein — Hyccin

Introduction

FAM126A Protein — Hyccin

Introduction

Overview

Structure

Normal Function

Myelin Formation

Oligodendrocyte Differentiation

Lipid Metabolism

PI3K/AKT Signaling

Role in Disease

Hypomagnesemia with Neurological Symptoms (HSMA)

Multiple Sclerosis

Leukodystrophies

Other Neurodegenerative Conditions

Therapeutic Targeting

Interacting Proteins

Key Publications

Cross-Links

See Also

References